Alphabet Inc. vs. REGEN BIOPHARMA INC
Alphabet Inc. and REGEN BIOPHARMA INC are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| GOOGL | RGBP | |
|---|---|---|
| Market Cap | $4.19 trillion | — |
| Revenue (TTM) | $445.87 billion | — |
| Net Income (TTM) | $244.21 billion | — |
GOOGL and RGBP split the size & scale factors evenly.
Valuation
| GOOGL | RGBP | |
|---|---|---|
| P/E Ratio | 16.98 | — |
| Price / Book | 6.54 | — |
| Price / Sales | 9.39 | — |
GOOGL and RGBP split the valuation factors evenly.
Profitability
| GOOGL | RGBP | |
|---|---|---|
| Net Margin | 54.77% | — |
| Return on Equity | 38.13% | — |
GOOGL and RGBP split the profitability factors evenly.
Dividend
| GOOGL | RGBP | |
|---|---|---|
| Dividend Yield | 0.26% | — |
| Payout Ratio | 4.42 | — |
GOOGL and RGBP split the dividend factors evenly.
Risk & Sentiment
| GOOGL | RGBP | |
|---|---|---|
| Short Interest | 0.05% | — |
GOOGL and RGBP split the risk & sentiment factors evenly.
Dig deeper: GOOGL overview, GOOGL financials, RGBP overview, RGBP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.